nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0818	0.108	CbGbCtD
Pyrazinamide—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0769	0.102	CbGbCtD
Pyrazinamide—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0769	0.102	CbGbCtD
Pyrazinamide—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0695	0.092	CbGbCtD
Pyrazinamide—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0583	0.0771	CbGbCtD
Pyrazinamide—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0527	0.0697	CbGbCtD
Pyrazinamide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0428	0.0567	CbGbCtD
Pyrazinamide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0403	0.0533	CbGbCtD
Pyrazinamide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0403	0.0533	CbGbCtD
Pyrazinamide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0364	0.0482	CbGbCtD
Pyrazinamide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0364	0.0482	CbGbCtD
Pyrazinamide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0314	0.0416	CbGbCtD
Pyrazinamide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0305	0.0404	CbGbCtD
Pyrazinamide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0276	0.0365	CbGbCtD
Pyrazinamide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0276	0.0365	CbGbCtD
Pyrazinamide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0265	0.035	CbGbCtD
Pyrazinamide—Malaise—Didanosine—acquired immunodeficiency syndrome	0.000934	0.00383	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Efavirenz—acquired immunodeficiency syndrome	0.000899	0.00369	CcSEcCtD
Pyrazinamide—Hepatitis—Zidovudine—acquired immunodeficiency syndrome	0.000897	0.00368	CcSEcCtD
Pyrazinamide—Anorexia—Amprenavir—acquired immunodeficiency syndrome	0.000883	0.00362	CcSEcCtD
Pyrazinamide—Arthralgia—Didanosine—acquired immunodeficiency syndrome	0.000881	0.00361	CcSEcCtD
Pyrazinamide—Myalgia—Didanosine—acquired immunodeficiency syndrome	0.000881	0.00361	CcSEcCtD
Pyrazinamide—Discomfort—Didanosine—acquired immunodeficiency syndrome	0.000871	0.00357	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Nevirapine—acquired immunodeficiency syndrome	0.000864	0.00354	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.000844	0.00346	CcSEcCtD
Pyrazinamide—Malaise—Nevirapine—acquired immunodeficiency syndrome	0.000839	0.00344	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000836	0.00343	CcSEcCtD
Pyrazinamide—Hepatitis—Indinavir—acquired immunodeficiency syndrome	0.000835	0.00342	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.000827	0.00339	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Abacavir—acquired immunodeficiency syndrome	0.000821	0.00337	CcSEcCtD
Pyrazinamide—Dysuria—Ritonavir—acquired immunodeficiency syndrome	0.000815	0.00334	CcSEcCtD
Pyrazinamide—Malaise—Nelfinavir—acquired immunodeficiency syndrome	0.000813	0.00333	CcSEcCtD
Pyrazinamide—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.000806	0.0033	CcSEcCtD
Pyrazinamide—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.000805	0.0033	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.0008	0.00328	CcSEcCtD
Pyrazinamide—Malaise—Abacavir—acquired immunodeficiency syndrome	0.000798	0.00327	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.000796	0.00326	CcSEcCtD
Pyrazinamide—Arthralgia—Nevirapine—acquired immunodeficiency syndrome	0.000792	0.00325	CcSEcCtD
Pyrazinamide—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.000792	0.00325	CcSEcCtD
Pyrazinamide—Hepatitis—Efavirenz—acquired immunodeficiency syndrome	0.000788	0.00323	CcSEcCtD
Pyrazinamide—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000783	0.00321	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.00077	0.00315	CcSEcCtD
Pyrazinamide—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.000768	0.00315	CcSEcCtD
Pyrazinamide—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.000768	0.00315	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.000766	0.00314	CcSEcCtD
Pyrazinamide—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.000765	0.00314	CcSEcCtD
Pyrazinamide—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.000765	0.00314	CcSEcCtD
Pyrazinamide—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000758	0.00311	CcSEcCtD
Pyrazinamide—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.000754	0.00309	CcSEcCtD
Pyrazinamide—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.000754	0.00309	CcSEcCtD
Pyrazinamide—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.000754	0.00309	CcSEcCtD
Pyrazinamide—Dysuria—Lamivudine—acquired immunodeficiency syndrome	0.000748	0.00307	CcSEcCtD
Pyrazinamide—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.000745	0.00305	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000744	0.00305	CcSEcCtD
Pyrazinamide—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000744	0.00305	CcSEcCtD
Pyrazinamide—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000734	0.00301	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Zidovudine—acquired immunodeficiency syndrome	0.000725	0.00297	CcSEcCtD
Pyrazinamide—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000724	0.00297	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00072	0.00295	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000718	0.00294	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000707	0.0029	CcSEcCtD
Pyrazinamide—Malaise—Zidovudine—acquired immunodeficiency syndrome	0.000704	0.00289	CcSEcCtD
Pyrazinamide—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000701	0.00287	CcSEcCtD
Pyrazinamide—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000699	0.00287	CcSEcCtD
Pyrazinamide—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000698	0.00286	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000692	0.00284	CcSEcCtD
Pyrazinamide—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000689	0.00282	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.000674	0.00276	CcSEcCtD
Pyrazinamide—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000671	0.00275	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00067	0.00275	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000668	0.00274	CcSEcCtD
Pyrazinamide—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000668	0.00274	CcSEcCtD
Pyrazinamide—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000665	0.00273	CcSEcCtD
Pyrazinamide—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000665	0.00273	CcSEcCtD
Pyrazinamide—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00066	0.00271	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000658	0.0027	CcSEcCtD
Pyrazinamide—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000657	0.00269	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000656	0.00269	CcSEcCtD
Pyrazinamide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000656	0.00269	CcSEcCtD
Pyrazinamide—Malaise—Indinavir—acquired immunodeficiency syndrome	0.000655	0.00269	CcSEcCtD
Pyrazinamide—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000648	0.00265	CcSEcCtD
Pyrazinamide—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000646	0.00265	CcSEcCtD
Pyrazinamide—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000641	0.00263	CcSEcCtD
Pyrazinamide—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00064	0.00262	CcSEcCtD
Pyrazinamide—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000638	0.00261	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.000637	0.00261	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000635	0.0026	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000633	0.0026	CcSEcCtD
Pyrazinamide—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000628	0.00257	CcSEcCtD
Pyrazinamide—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000626	0.00257	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000624	0.00256	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000624	0.00256	CcSEcCtD
Pyrazinamide—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000622	0.00255	CcSEcCtD
Pyrazinamide—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000619	0.00254	CcSEcCtD
Pyrazinamide—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000618	0.00253	CcSEcCtD
Pyrazinamide—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000618	0.00253	CcSEcCtD
Pyrazinamide—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000611	0.0025	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000609	0.0025	CcSEcCtD
Pyrazinamide—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000608	0.00249	CcSEcCtD
Pyrazinamide—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000606	0.00248	CcSEcCtD
Pyrazinamide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000604	0.00247	CcSEcCtD
Pyrazinamide—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000601	0.00246	CcSEcCtD
Pyrazinamide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000598	0.00245	CcSEcCtD
Pyrazinamide—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000595	0.00244	CcSEcCtD
Pyrazinamide—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000592	0.00243	CcSEcCtD
Pyrazinamide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000589	0.00242	CcSEcCtD
Pyrazinamide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000584	0.0024	CcSEcCtD
Pyrazinamide—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000584	0.0024	CcSEcCtD
Pyrazinamide—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000584	0.0024	CcSEcCtD
Pyrazinamide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000584	0.0024	CcSEcCtD
Pyrazinamide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000584	0.00239	CcSEcCtD
Pyrazinamide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000583	0.00239	CcSEcCtD
Pyrazinamide—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000582	0.00238	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000581	0.00238	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000581	0.00238	CcSEcCtD
Pyrazinamide—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00058	0.00238	CcSEcCtD
Pyrazinamide—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000577	0.00237	CcSEcCtD
Pyrazinamide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000574	0.00235	CcSEcCtD
Pyrazinamide—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000571	0.00234	CcSEcCtD
Pyrazinamide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000565	0.00232	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000563	0.00231	CcSEcCtD
Pyrazinamide—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000561	0.0023	CcSEcCtD
Pyrazinamide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00056	0.00229	CcSEcCtD
Pyrazinamide—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000559	0.00229	CcSEcCtD
Pyrazinamide—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000559	0.00229	CcSEcCtD
Pyrazinamide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000554	0.00227	CcSEcCtD
Pyrazinamide—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000552	0.00226	CcSEcCtD
Pyrazinamide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00055	0.00226	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00055	0.00226	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000548	0.00225	CcSEcCtD
Pyrazinamide—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000548	0.00224	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000542	0.00222	CcSEcCtD
Pyrazinamide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000542	0.00222	CcSEcCtD
Pyrazinamide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00054	0.00221	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00054	0.00221	CcSEcCtD
Pyrazinamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000537	0.0022	CcSEcCtD
Pyrazinamide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000537	0.0022	CcSEcCtD
Pyrazinamide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000534	0.00219	CcSEcCtD
Pyrazinamide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000533	0.00218	CcSEcCtD
Pyrazinamide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000532	0.00218	CcSEcCtD
Pyrazinamide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000532	0.00218	CcSEcCtD
Pyrazinamide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000527	0.00216	CcSEcCtD
Pyrazinamide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000525	0.00215	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000525	0.00215	CcSEcCtD
Pyrazinamide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000522	0.00214	CcSEcCtD
Pyrazinamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000521	0.00213	CcSEcCtD
Pyrazinamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000519	0.00213	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000517	0.00212	CcSEcCtD
Pyrazinamide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000517	0.00212	CcSEcCtD
Pyrazinamide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000517	0.00212	CcSEcCtD
Pyrazinamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000515	0.00211	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000512	0.0021	CcSEcCtD
Pyrazinamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000511	0.0021	CcSEcCtD
Pyrazinamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000511	0.00209	CcSEcCtD
Pyrazinamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000511	0.00209	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00051	0.00209	CcSEcCtD
Pyrazinamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000506	0.00208	CcSEcCtD
Pyrazinamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000504	0.00207	CcSEcCtD
Pyrazinamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000503	0.00206	CcSEcCtD
Pyrazinamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000502	0.00206	CcSEcCtD
Pyrazinamide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000498	0.00204	CcSEcCtD
Pyrazinamide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000498	0.00204	CcSEcCtD
Pyrazinamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000493	0.00202	CcSEcCtD
Pyrazinamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000492	0.00202	CcSEcCtD
Pyrazinamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000489	0.002	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000488	0.002	CcSEcCtD
Pyrazinamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000487	0.002	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000485	0.00199	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000484	0.00198	CcSEcCtD
Pyrazinamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000483	0.00198	CcSEcCtD
Pyrazinamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000479	0.00196	CcSEcCtD
Pyrazinamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000479	0.00196	CcSEcCtD
Pyrazinamide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000475	0.00195	CcSEcCtD
Pyrazinamide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000475	0.00195	CcSEcCtD
Pyrazinamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000472	0.00194	CcSEcCtD
Pyrazinamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000472	0.00193	CcSEcCtD
Pyrazinamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000471	0.00193	CcSEcCtD
Pyrazinamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000469	0.00192	CcSEcCtD
Pyrazinamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000469	0.00192	CcSEcCtD
Pyrazinamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000468	0.00192	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000467	0.00191	CcSEcCtD
Pyrazinamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000466	0.00191	CcSEcCtD
Pyrazinamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000466	0.00191	CcSEcCtD
Pyrazinamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000464	0.0019	CcSEcCtD
Pyrazinamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000463	0.0019	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000463	0.0019	CcSEcCtD
Pyrazinamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000462	0.0019	CcSEcCtD
Pyrazinamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000462	0.00189	CcSEcCtD
Pyrazinamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000462	0.00189	CcSEcCtD
Pyrazinamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000459	0.00188	CcSEcCtD
Pyrazinamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000456	0.00187	CcSEcCtD
Pyrazinamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000455	0.00187	CcSEcCtD
Pyrazinamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000455	0.00186	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000452	0.00185	CcSEcCtD
Pyrazinamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000451	0.00185	CcSEcCtD
Pyrazinamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000451	0.00185	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000446	0.00183	CcSEcCtD
Pyrazinamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000445	0.00182	CcSEcCtD
Pyrazinamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000443	0.00182	CcSEcCtD
Pyrazinamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000442	0.00181	CcSEcCtD
Pyrazinamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000437	0.00179	CcSEcCtD
Pyrazinamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000437	0.00179	CcSEcCtD
Pyrazinamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000436	0.00179	CcSEcCtD
Pyrazinamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000436	0.00179	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000435	0.00178	CcSEcCtD
Pyrazinamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000434	0.00178	CcSEcCtD
Pyrazinamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.00177	CcSEcCtD
Pyrazinamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000429	0.00176	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000428	0.00175	CcSEcCtD
Pyrazinamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000426	0.00175	CcSEcCtD
Pyrazinamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000424	0.00174	CcSEcCtD
Pyrazinamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00042	0.00172	CcSEcCtD
Pyrazinamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000419	0.00172	CcSEcCtD
Pyrazinamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.0017	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000415	0.0017	CcSEcCtD
Pyrazinamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000413	0.00169	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000412	0.00169	CcSEcCtD
Pyrazinamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000408	0.00167	CcSEcCtD
Pyrazinamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000405	0.00166	CcSEcCtD
Pyrazinamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000402	0.00165	CcSEcCtD
Pyrazinamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000402	0.00165	CcSEcCtD
Pyrazinamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000401	0.00164	CcSEcCtD
Pyrazinamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000396	0.00162	CcSEcCtD
Pyrazinamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.00162	CcSEcCtD
Pyrazinamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000395	0.00162	CcSEcCtD
Pyrazinamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000394	0.00161	CcSEcCtD
Pyrazinamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000393	0.00161	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000393	0.00161	CcSEcCtD
Pyrazinamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000392	0.00161	CcSEcCtD
Pyrazinamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000379	0.00155	CcSEcCtD
Pyrazinamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000379	0.00155	CcSEcCtD
Pyrazinamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000379	0.00155	CcSEcCtD
Pyrazinamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000377	0.00155	CcSEcCtD
Pyrazinamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000377	0.00155	CcSEcCtD
Pyrazinamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000375	0.00154	CcSEcCtD
Pyrazinamide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000374	0.00153	CcSEcCtD
Pyrazinamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000373	0.00153	CcSEcCtD
Pyrazinamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000365	0.0015	CcSEcCtD
Pyrazinamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000362	0.00148	CcSEcCtD
Pyrazinamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00036	0.00147	CcSEcCtD
Pyrazinamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000356	0.00146	CcSEcCtD
Pyrazinamide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000353	0.00145	CcSEcCtD
Pyrazinamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000353	0.00145	CcSEcCtD
Pyrazinamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000352	0.00144	CcSEcCtD
Pyrazinamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000351	0.00144	CcSEcCtD
Pyrazinamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.00144	CcSEcCtD
Pyrazinamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.0014	CcSEcCtD
Pyrazinamide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000338	0.00139	CcSEcCtD
Pyrazinamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000338	0.00138	CcSEcCtD
Pyrazinamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000338	0.00138	CcSEcCtD
Pyrazinamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000335	0.00137	CcSEcCtD
Pyrazinamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000333	0.00136	CcSEcCtD
Pyrazinamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.00132	CcSEcCtD
Pyrazinamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000318	0.0013	CcSEcCtD
Pyrazinamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.00129	CcSEcCtD
Pyrazinamide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00128	CcSEcCtD
Pyrazinamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00128	CcSEcCtD
Pyrazinamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.00124	CcSEcCtD
Pyrazinamide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.00123	CcSEcCtD
Pyrazinamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.00123	CcSEcCtD
Pyrazinamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.00121	CcSEcCtD
Pyrazinamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00119	CcSEcCtD
Pyrazinamide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00118	CcSEcCtD
Pyrazinamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00118	CcSEcCtD
Pyrazinamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.00116	CcSEcCtD
Pyrazinamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.00111	CcSEcCtD
